Vertiv (VRT) Stock Price, News & Analysis

Company Overview

Veritas Pharma Inc., through its subsidiary, Cannevert Therapeutics Ltd. operates as a pharmaceutical and IP development company. It develops proprietary cannabis strains for chronic and acute pains, nausea and vomiting, and post-traumatic stress disorders. The company was formerly known as Seashore Organic Medicine Inc. and changed its name to Veritas Pharma Inc. in December 2015. Veritas Pharma Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 2,475 shs
• Average Volume: 73,073 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VRT Stock Analysis - Frequently Asked Questions

How do I buy shares of Vertiv?

Shares of VRT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Vertiv own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Vertiv investors own include NVIDIA (NVDA), Arista Networks (ANET), ARM (ARM), PACCAR (PCAR), Meta Platforms (META), Micron Technology (MU) and Novo Nordisk A/S (NVO).

Industry, Sector and Symbol

• Stock Exchange: CNSX
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Electronic Equipment
• Current Symbol: CNSX:VRT
• CUSIP: N/A
• CIK: N/A
• Web: www.veritaspharmainc.com
• Phone: 16148880246
• Fax: N/A
• Employees: 27,000
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A